KHAN, K. . Efficacy and safety of sitagliptin, metformin and pioglitazone fixed-dose combination therapy (100 mg/1000mg and 15 mg respectively) as a first-line treatment in obese type 2 diabetes with high insulin resistance. International Journal of Medical and Biomedical Studies, [S. l.], v. 9, n. 1, p. 247–251, 2025. DOI: 10.32553/ijmbs.v9i1.3064. Disponível em: https://www.ijmbs.info/index.php/ijmbs/article/view/3064. Acesso em: 27 apr. 2026.